We are live on
!
Find out more
RCP
Rothschild Capital Partners Portfolio holdings
AUM
$408M
1-Year Est. Return
25.87%
This Fund
S&P 500
This Quarter
Est. Return
+3.29%
1 Year Est. Return
+25.87%
3 Year Est. Return
+81.82%
5 Year Est. Return
+111.3%
10 Year Est. Return
+529.64%
AUM
$232M
AUM Growth
+$8.04M
(+3.6%)
Cap. Flow
-$626K
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
52.2%
Holding
52
New
11
Increased
12
Reduced
16
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$6.58M |
| 2 |
Edgewell Personal Care
EPC
|
+$5.68M |
| 3 |
CTXS
Citrix Systems Inc
CTXS
|
+$5.6M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$4.78M |
| 5 |
WisdomTree Europe Hedged Equity Fund
HEDJ
|
+$3.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Insulet
PODD
|
+$12.8M |
| 2 |
Starwood Property Trust
STWD
|
+$6.82M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$5.44M |
| 4 |
DexCom
DXCM
|
+$5.02M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$4.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.17% |
| 2 | Technology | 19.66% |
| 3 | Communication Services | 11.92% |
| 4 | Energy | 7.18% |
| 5 | Industrials | 4.12% |
Similar funds
CIM
LECM
PWP
DW
OCP
HWM
AEPWM
MCM
Rothschild Capital Partners's Q2 2015 Portfolio in Review
As of Q2 2015, Rothschild Capital Partners held 52 positions worth $232M, up 3.6% from $224M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Rothschild Capital Partners's Q2 2015 filing shows 11 new, 12 increased, 16 reduced and 6 closed positions. Its largest new stake was Cardiovascular Systems, Inc.: 203,715 shares worth $5.39M. The largest sale was Insulet, an estimated $12.8M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 30% a quarter earlier, followed by Technology and Communication Services.
- Rothschild Capital Partners's largest Q2 2015 buy was Cardiovascular Systems, Inc.: 203,715 shares worth $5.39M.
- Rothschild Capital Partners added most to State Street SPDR S&P Regional Banking ETF in Q2 2015, an estimated $4.78M increase.
- Rothschild Capital Partners's biggest Q2 2015 reduction was Thermo Fisher Scientific, cutting an estimated $5.44M.
- Rothschild Capital Partners fully exited Insulet in Q2 2015, selling an estimated $12.8M.
- Rothschild Capital Partners's ten largest holdings make up 52% of its $232M portfolio in Q2 2015.
- Rothschild Capital Partners opened 11 new positions and closed 6 in Q2 2015.
- Rothschild Capital Partners's portfolio value rose 3.6% quarter-over-quarter to $232M.
Based on Rothschild Capital Partners's 13F filing for Q2 2015, filed 31 Jul 2015.